with MM in Sweden, over a period of more than 50 years. This study aimed to investigate
the effects of second malignancies on survival and assess changes following the
introduction of modern myeloma therapy. Furthermore, as AML/MDS is over-represented in
MM patients, we assessed patterns of survival specifically in these patients. …